Welcome to our dedicated page for National Vision SEC filings (Ticker: EYE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for National Vision Holdings, Inc. (NASDAQ: EYE), a Delaware-incorporated optical retail company. As a Nasdaq-listed issuer, National Vision files annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, along with other required documents. These filings offer detailed information on the company’s financial condition, risk factors, governance, and material events.
National Vision’s Form 8-K filings have covered topics such as quarterly financial results, amendments to material agreements, annual meeting voting outcomes, and changes in directors and executive officers. For example, recent 8-Ks have reported results of operations and financial condition, board and leadership changes, and an amendment to a letter agreement with a key business partner. These documents help investors track developments that the company deems material.
In its SEC reports, National Vision discusses its optical retail operations, including its store footprint, brand portfolio, and operating segments, as well as non-GAAP financial measures like Adjusted Operating Income, Adjusted Operating Margin, Adjusted Diluted EPS, and Adjusted Comparable Store Sales Growth. The filings describe how these measures are defined and reconciled to GAAP, and outline the risks and uncertainties that could affect future performance, such as competition, macroeconomic conditions, technology investments, regulatory compliance, and vendor relationships.
On Stock Titan, National Vision’s filings are updated as they are released on EDGAR, and AI-powered summaries can help explain the key points in lengthy documents such as 10-K and 10-Q reports or detailed 8-K disclosures. Users can also review information related to governance matters, executive and director changes, and other regulatory disclosures associated with the EYE ticker.
National Vision Holdings senior vice president and chief people officer Bill Clark reported equity award activity. On restricted stock units, he exercised or converted 3,363 units into an equal number of common shares on a one-for-one basis.
He then disposed of 1,172 common shares at $26.97 per share to cover tax withholding tied to the vesting of these restricted stock units. After these transactions, his directly owned common stock holdings were 42,251 shares.
National Vision Holdings, Inc. Chief Legal & Strategy Officer Jared Brandman reported equity award activity involving restricted stock units and common stock of EYE. On February 27, 2026, 3,540 restricted stock units were exercised and converted into the same number of shares of common stock at a price of $0.00 per share.
A separate transaction on the same date shows a disposition of 1,205 shares of common stock at $26.97 per share to cover tax liabilities associated with the vesting of restricted stock units, as described in the footnotes. After these transactions, Brandman directly held 47,040 shares of common stock and 44,510 restricted stock units.
The footnotes also state that on March 1, 2024, Brandman was granted 10,621 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date, with each unit converting into one share of common stock upon vesting.
National Vision Holdings Executive Chairman Fahs L. Reade reported equity award activity. On February 27, 2026, 28,321 restricted stock units converted into the same number of common shares at $0.00 per share. To cover taxes on this vesting, 12,708 common shares were withheld at $26.97 per share, classified as a tax-liability disposition rather than an open-market sale. Following these transactions, Reade directly held 547,808 common shares and indirectly held 363,430 shares through a trust. Footnotes note these RSUs come from an 84,962-unit grant made on March 1, 2024, vesting in three equal annual installments.
National Vision Holdings, Inc. received an amended Schedule 13G from American Century Investment Management, American Century Companies, and the Stowers Institute for Medical Research reporting a sizable institutional stake. The group reports beneficial ownership of 3,580,367 shares of common stock, representing 4.5% of the outstanding class.
The filers report sole voting power over 2,523,641 shares and sole dispositive power over all 3,580,367 shares as of the event date. They certify the shares were acquired and are held in the ordinary course of business, not to change or influence control of National Vision.
National Vision Holdings, Inc. (EYE) received an updated large‑holder disclosure from Wellington-affiliated entities. Wellington Management Group LLP and related entities report beneficial ownership of 5,783,699 shares of National Vision common stock, representing about 7.29% of the outstanding class as of the event date.
The filing shows no sole voting or dispositive power; voting power over 2,760,987 shares and dispositive power over 5,783,699 shares are held on a shared basis among Wellington entities. The securities are held of record by clients of Wellington investment advisers, whose clients receive dividends and sale proceeds.
Wellington certifies the shares were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing control of National Vision, other than activities solely in connection with certain nomination rules.
National Vision Holdings, Inc. reported that its subsidiary, National Vision, Inc., and Essilor of America, Inc. signed a Third Amendment to their Direct Lens Letter Agreement. The amendment extends the agreement’s initial term by two years, moving the end date from May 31, 2026 to May 31, 2028.
The amendment also updates the pricing terms between the parties, though specific pricing details are not described here. This keeps a key lens supply relationship in place for a longer period, providing more contractual visibility for both companies.
National Vision Holdings (EYE) reported Q3 results. Total net revenue was $487.3 million versus $451.5 million a year ago, driven by higher product sales and services. Income from operations was $9.6 million, compared to a loss last year, and net income was $3.4 million, or $0.04 per diluted share, versus a loss of $0.11. For the first nine months, revenue reached $1.48 billion with net income of $26.3 million, or $0.33 per diluted share.
Operating cash flow was $133.1 million for the nine months, supporting capital expenditures and debt reduction. The company fully repaid its 2.50% convertible senior notes due May 2025 and ended the quarter with Term Loan A of $244.3 million and no revolver borrowings. Cash and cash equivalents were $56.0 million. The company operated 1,242 stores as of September 27, 2025. Subsequent to quarter‑end, an investee agreed to be acquired, and EYE expects repayment in cash of its preferred equity and note balances with no gain or loss.
National Vision Holdings, Inc. (EYE) furnished a Form 8-K announcing it issued a press release with financial results for the quarter ended September 27, 2025. The press release is included as Exhibit 99.1 pursuant to Item 2.02 (Results of Operations and Financial Condition).
The information is being furnished to the SEC and is not deemed filed under Section 18 of the Exchange Act, nor incorporated by reference unless specifically stated.
National Vision Holdings, Inc. (EYE) insider reporting: The filing discloses that Priti V. Patel, a General Manager and officer, had 1,502 restricted stock units vest on 10/03/2025, which converted one-for-one into 1,502 shares of common stock. The filing shows tax withholding of 538 shares to satisfy taxes at a withholding price of $28.87, leaving 13,869 shares beneficially owned after the transaction. Total restricted stock units originally granted were 4,506 on 10/03/2022, vesting in three equal installments beginning one year after grant.
The Form 4 was signed by an attorney-in-fact on 10/06/2025
FAHS L Reade, Executive Chairman and Director of National Vision Holdings, Inc. (EYE), reported two open-market sales of company common stock on 09/15/2025 and 09/16/2025 executed under a Rule 10b5-1 trading plan established May 28, 2025. The filing shows a sale of 2,002 shares on 09/15/2025 at a weighted average price of $23.81 and a sale of 10,598 shares on 09/16/2025 at a weighted average price of $23.93. After those transactions the reporting person directly beneficially owned 532,195 shares. The filing also discloses 363,430 shares indirectly held by a trust. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.